These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10976393)

  • 1. The role of single nucleotide polymorphisms (SNPs) in understanding complex disorders and pharmacogenomics.
    Kao SL; Chong SS; Lee CG
    Ann Acad Med Singap; 2000 May; 29(3):376-82. PubMed ID: 10976393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of drug transporters: a new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1).
    Ishikawa T; Onishi Y; Hirano H; Oosumi K; Nagakura M; Tarui S
    Biol Pharm Bull; 2004 Jul; 27(7):939-48. PubMed ID: 15256718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphism and its dynamics for pharmacogenomics.
    Katara P
    Interdiscip Sci; 2014 Jun; 6(2):85-92. PubMed ID: 25172446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of single nucleotide polymorphisms and haplotype linkage of the human ABCB1 (MDR1) gene in Korean.
    Ryu HC; Kwon HY; Choi IK; Rhee DK
    Arch Pharm Res; 2006 Dec; 29(12):1132-9. PubMed ID: 17225463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
    Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
    Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.
    Kimchi-Sarfaty C; Marple AH; Shinar S; Kimchi AM; Scavo D; Roma MI; Kim IW; Jones A; Arora M; Gribar J; Gurwitz D; Gottesman MM
    Pharmacogenomics; 2007 Jan; 8(1):29-39. PubMed ID: 17187507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of single-nucleotide polymorphism maps in pharmacogenomics.
    McCarthy JJ; Hilfiker R
    Nat Biotechnol; 2000 May; 18(5):505-8. PubMed ID: 10802616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Techniques patents for SNP genotyping.
    Twyman RM; Primrose SB
    Pharmacogenomics; 2003 Jan; 4(1):67-79. PubMed ID: 12517287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives.
    Anglicheau D; Legendre C; Thervet E
    Transplantation; 2004 Aug; 78(3):311-5. PubMed ID: 15316356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical impact of ABCB1 polymorphisms on the treatment of psychiatric diseases.
    Rosenhagen MC; Uhr M
    Curr Pharm Des; 2011; 17(26):2843-51. PubMed ID: 21827404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition.
    Haufroid V
    Curr Drug Targets; 2011 May; 12(5):631-46. PubMed ID: 21039333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics: the influence of genomic variation on drug response.
    Thomas FJ; McLeod HL; Watters JW
    Curr Top Med Chem; 2004; 4(13):1399-409. PubMed ID: 15379653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNP web resources and their potential applications in personalized medicine.
    Wang J; Pang GS; Chong SS; Lee CG
    Curr Drug Metab; 2012 Sep; 13(7):978-90. PubMed ID: 22591348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics of human ABC transporters: detection of clinically important SNPs by SmartAmp2 method.
    Aw W; Ota I; Toyoda Y; Lezhava A; Sakai Y; Gomi T; Hayashizaki Y; Ishikawa T
    Curr Pharm Biotechnol; 2011 Apr; 12(4):693-704. PubMed ID: 21118085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin.
    Horinouchi M; Sakaeda T; Nakamura T; Morita Y; Tamura T; Aoyama N; Kasuga M; Okumura K
    Pharm Res; 2002 Oct; 19(10):1581-5. PubMed ID: 12425480
    [No Abstract]   [Full Text] [Related]  

  • 17. Candidate gene approach for pharmacogenetic studies.
    Ring HZ; Kroetz DL
    Pharmacogenomics; 2002 Jan; 3(1):47-56. PubMed ID: 11966402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-nucleotide polymorphisms, haplotypes, and their relevance to pharmacogenetics.
    Stephens JC
    Mol Diagn; 1999 Dec; 4(4):309-17. PubMed ID: 10671641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of drug transporters and its impact on the pharmacotherapy.
    Sakaeda T; Nakamura T; Okumura K
    Curr Top Med Chem; 2004; 4(13):1385-98. PubMed ID: 15379652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases.
    Chaudhary R; Singh B; Kumar M; Gakhar SK; Saini AK; Parmar VS; Chhillar AK
    Drug Metab Rev; 2015 Aug; 47(3):281-90. PubMed ID: 25996670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.